Oral chemotherapy pill tested for advanced breast cancer
NCT ID NCT06500494
First seen Jul 02, 2026 · Last updated Jul 02, 2026
Summary
This study looks at how well oral vinorelbine, a chemotherapy pill, works in women with advanced breast cancer. It includes women who have already taken the drug or are starting it now. Researchers track how long the cancer stays under control and how patients feel during treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
oral vinorelbine (Navelbine)
What this could lead to
If results are positive, this could confirm oral vinorelbine as a reliable chemotherapy option for advanced breast cancer, offering a convenient at-home treatment.
What could go wrong
This is an observational study, not a controlled trial, so it cannot prove cause and effect. Results may be influenced by patient selection or other treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- ctDNA Testing in Advanced Breast Cancer (NCT07681323)
- EMBER Trial: Imlunestrant for ER+ Breast Cancer NCT04188548
- Electroacupuncture to Prevent Chemo Nerve Damage NCT07644533
- Deruxtepruzumab for Advanced Breast Cancer – NCT07670182
- Breast Cancer Treatment Study (NCT03417115)
- Radiotherapy-Sensitized Immunotherapy for Advanc NCT06776861
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Azienda Ospedaliera San Gerardo U.O. Oncologia Medica
Monza, 20052, Italy
-
Centre Hospitalo-Universitaire Mustapha, Hopital Mustapha, Place du 1er Mai 1945, Sidi M'Hamed
Algiers, 16000, Algeria
-
Tianjing Medical University Cancer Institute & Hospital
Tianjin, Tianjin Municipality, 360060, China